Cargando…

Can academic detailing reduce opioid prescriptions in chronic non-cancer pain?

BACKGROUND: One measure to support optimal opioid prescription is academic detailing (AD) with one-to-one visits by trained professionals (academic detailers) to general practitioners (GPs). Objective: To investigate the usefulness of AD visits on GPs’ opioid prescribing patterns in Norway, and acad...

Descripción completa

Detalles Bibliográficos
Autores principales: Espnes, Ketil Arne, Nøst, Torunn Hatlen, Handal, Marte, Skurtveit, Svetlana O., Langaas, Harald C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042395/
https://www.ncbi.nlm.nih.gov/pubmed/36973685
http://dx.doi.org/10.1186/s12875-023-02040-6
_version_ 1784912925515841536
author Espnes, Ketil Arne
Nøst, Torunn Hatlen
Handal, Marte
Skurtveit, Svetlana O.
Langaas, Harald C.
author_facet Espnes, Ketil Arne
Nøst, Torunn Hatlen
Handal, Marte
Skurtveit, Svetlana O.
Langaas, Harald C.
author_sort Espnes, Ketil Arne
collection PubMed
description BACKGROUND: One measure to support optimal opioid prescription is academic detailing (AD) with one-to-one visits by trained professionals (academic detailers) to general practitioners (GPs). Objective: To investigate the usefulness of AD visits on GPs’ opioid prescribing patterns in Norway, and academic detailers’ experiences with AD visits to GPs on opioid prescription. METHODS: Design: A quantitative registry study on opioid prescriptions and a qualitative focus group interview study with academic detailers. Participants: For the registry study, municipalities where more than 75% of the GPs had received an AD visit were considered intervention municipalities, whereas in the non-intervention municipalities no GPs had received AD-visits. In the focus groups, academic detailers who had conducted three or more AD-visits were invited to participate. Intervention: A campaign on opioid prescription with AD visits using a brochure with key messages based on the national guideline for treatment of chronic non-cancer pain and updated evidence on the potential benefits and risks of prescribing opioids. The AD visits in the campaign were planned for 20–25 min in a one-to-one setting in the GP’s office. Main Measures: The Norwegian Prescription Database (NorPD) was utilized for registry data. Data on amount of drugs dispensed are recoded as Defined Daily Doses (DDDs). RESULTS: Compared to non-intervention, the intervention resulted in a decrease in the number of prevalent and incident users of opioids and incident users of reimbursed opioids for chronic non-cancer pain in municipalities in Central Norway. The results from the focus group interviews were categorized into the themes: “To get in position”, “Adjusting messages”, “What did the GPs struggle with, in relation to opioid prescription?” and “Did we reach the right recipients with the visits?”. CONCLUSIONS: In Central Norway, the intervention resulted in a desired effect on number of opioid users. According to the academic detailers, the GPs’ length of working experience and familiarity with the topic gave different presumptions for making use of the information presented in the AD-visits. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12875-023-02040-6.
format Online
Article
Text
id pubmed-10042395
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100423952023-03-28 Can academic detailing reduce opioid prescriptions in chronic non-cancer pain? Espnes, Ketil Arne Nøst, Torunn Hatlen Handal, Marte Skurtveit, Svetlana O. Langaas, Harald C. BMC Prim Care Research Article BACKGROUND: One measure to support optimal opioid prescription is academic detailing (AD) with one-to-one visits by trained professionals (academic detailers) to general practitioners (GPs). Objective: To investigate the usefulness of AD visits on GPs’ opioid prescribing patterns in Norway, and academic detailers’ experiences with AD visits to GPs on opioid prescription. METHODS: Design: A quantitative registry study on opioid prescriptions and a qualitative focus group interview study with academic detailers. Participants: For the registry study, municipalities where more than 75% of the GPs had received an AD visit were considered intervention municipalities, whereas in the non-intervention municipalities no GPs had received AD-visits. In the focus groups, academic detailers who had conducted three or more AD-visits were invited to participate. Intervention: A campaign on opioid prescription with AD visits using a brochure with key messages based on the national guideline for treatment of chronic non-cancer pain and updated evidence on the potential benefits and risks of prescribing opioids. The AD visits in the campaign were planned for 20–25 min in a one-to-one setting in the GP’s office. Main Measures: The Norwegian Prescription Database (NorPD) was utilized for registry data. Data on amount of drugs dispensed are recoded as Defined Daily Doses (DDDs). RESULTS: Compared to non-intervention, the intervention resulted in a decrease in the number of prevalent and incident users of opioids and incident users of reimbursed opioids for chronic non-cancer pain in municipalities in Central Norway. The results from the focus group interviews were categorized into the themes: “To get in position”, “Adjusting messages”, “What did the GPs struggle with, in relation to opioid prescription?” and “Did we reach the right recipients with the visits?”. CONCLUSIONS: In Central Norway, the intervention resulted in a desired effect on number of opioid users. According to the academic detailers, the GPs’ length of working experience and familiarity with the topic gave different presumptions for making use of the information presented in the AD-visits. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12875-023-02040-6. BioMed Central 2023-03-27 /pmc/articles/PMC10042395/ /pubmed/36973685 http://dx.doi.org/10.1186/s12875-023-02040-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Espnes, Ketil Arne
Nøst, Torunn Hatlen
Handal, Marte
Skurtveit, Svetlana O.
Langaas, Harald C.
Can academic detailing reduce opioid prescriptions in chronic non-cancer pain?
title Can academic detailing reduce opioid prescriptions in chronic non-cancer pain?
title_full Can academic detailing reduce opioid prescriptions in chronic non-cancer pain?
title_fullStr Can academic detailing reduce opioid prescriptions in chronic non-cancer pain?
title_full_unstemmed Can academic detailing reduce opioid prescriptions in chronic non-cancer pain?
title_short Can academic detailing reduce opioid prescriptions in chronic non-cancer pain?
title_sort can academic detailing reduce opioid prescriptions in chronic non-cancer pain?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042395/
https://www.ncbi.nlm.nih.gov/pubmed/36973685
http://dx.doi.org/10.1186/s12875-023-02040-6
work_keys_str_mv AT espnesketilarne canacademicdetailingreduceopioidprescriptionsinchronicnoncancerpain
AT nøsttorunnhatlen canacademicdetailingreduceopioidprescriptionsinchronicnoncancerpain
AT handalmarte canacademicdetailingreduceopioidprescriptionsinchronicnoncancerpain
AT skurtveitsvetlanao canacademicdetailingreduceopioidprescriptionsinchronicnoncancerpain
AT langaasharaldc canacademicdetailingreduceopioidprescriptionsinchronicnoncancerpain